Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valcyte vs IV Ganciclovir for CMV in Transplant Patients
NCT00431353Phase 4Completed
- Sponsor
- Roche
- Start
- Apr 2004
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Roche. Started Apr 2004; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00431353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431353.